Research on desvenlafaxine's role in cancer care is still evolving. Studies have investigated its effects on quality of life measures in cancer patients, especially regarding mental health and menopausal symptoms. However, more extensive clinical trials are necessary to establish definitive benefits and guidelines for its use in oncology.
